Disseminated tuberculosis in a patient with hereditary C1-inhibitor deficiency

Infection

Volumn 36, Issue 2, 2008, Pages 181-183

  Kallel Sellami, M ^a   Blouin, J ^b   Abdelmalek, R ^a   Laadhar, L ^a   Zerzeri, Y ^a   Barbouche, M R ^c   Tiouiri, H ^a   Chaabene T ^a   Fremeaux Bacchi, V ^b   Zitouni, M ^a   Makni, S ^a  

^a LA RABTA HOSPITAL   (Tunisia)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANTIBIOTIC THERAPY; CASE REPORT; COMPLEMENT DEFICIENCY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LETTER; MALE; MILIARY TUBERCULOSIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TREATMENT OUTCOME; TUBERCULIN TEST;

ADULT; ANGIOEDEMA, HEREDITARY; COMPLEMENT C1 INHIBITOR PROTEIN; HUMANS; MALE; TUBERCULOSIS;

EID: 42249085426     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-7217-2     Document Type: Letter

References (14)

1. Walport MJ: Complement. First of two parts. N Engl J Med 2001; 344: 1058-1066.
2. Sjoholm AG, Jonsson G, Braconier JH, Sturfelt G, Truedsson L: Complement deficiency and disease: an update. Mol Immunol 2006; 43: 78-85.
3. Cicardi M, Zingale L, Zanichelli A, Pappalardo E, Cicardi B: C1 inhibitor: molecular and clinical aspects. Springer Semin Immunopathol 2005; 27: 286-298.
4. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, Fay AC, Longhurst HJ, Morrison L, Price A, Price M, Watters D: C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139: 379-394.
5. Cugno M, Nussberger J, Cicardi M, Agostoni A: Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003; 3: 311-317.
6. Jean Pierre M: A rapid method for the purification of DNA from blood. Nucleic Acids Res 1987; 25: 9611.
7. Verpy E, Biasotto M, Brai M, Misiano G, Meo T, Tosi M: Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. Am J Hum Genet 1996; 59: 308-319.
8. Casanova JL, Abel L: Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20: 581-620.
9. Cegielski JP, Chin DP, Espinal MA, Frieden TR, Rodriquez Cruz R, Talbot EA, Weil DEC, Zaleski R, Raviglione MC: The global tuberculosis situation. Progress and problems in the twentieth century, prospects for the twenty-first century. Infect Dis Clin North Am 2002; 16: 1-58.
10. Agostoni A, Cicardi M: Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992; 71: 206-215.
11. Ferguson JS, Weis JJ, Martin JL, Schlesinger LS: Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect Immun 2004; 72: 2564-2573.
12. Schlesinger LS: Mycobacterium tuberculosis and the complement system. Trends Microbiol 1998; 6: 47-49.
13. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A: Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 1994; 21: 125-131.
14. Mombo LE, Lu CY, Ossari S, Bedjabaga I, Sica L, Krishnamoorthy R, Lapoumeroulie C: Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections. Genes Immun 2003; 4: 362-367.